tiprankstipranks
Trending News
More News >
Inspira Technologies Oxy BHN (IINN)
NASDAQ:IINN
US Market
Advertisement

Inspira Technologies Oxy BHN (IINN) Price & Analysis

Compare
139 Followers

IINN Stock Chart & Stats

$1.18
-$0.05(-4.95%)
At close: 4:00 PM EST
$1.18
-$0.05(-4.95%)

Inspira Technologies Oxy BHN News

IINN FAQ

What was Inspira Technologies Oxy BHN’s price range in the past 12 months?
Inspira Technologies Oxy BHN lowest stock price was $0.40 and its highest was $1.65 in the past 12 months.
    What is Inspira Technologies Oxy BHN’s market cap?
    Inspira Technologies Oxy BHN’s market cap is $29.72M.
      When is Inspira Technologies Oxy BHN’s upcoming earnings report date?
      Inspira Technologies Oxy BHN’s upcoming earnings report date is Nov 19, 2025 which is in 34 days.
        How were Inspira Technologies Oxy BHN’s earnings last quarter?
        Inspira Technologies Oxy BHN released its earnings results on Oct 01, 2025. The company reported -$0.24 earnings per share for the quarter, missing the consensus estimate of -$0.22 by -$0.02.
          Is Inspira Technologies Oxy BHN overvalued?
          According to Wall Street analysts Inspira Technologies Oxy BHN’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Inspira Technologies Oxy BHN pay dividends?
            Inspira Technologies Oxy BHN does not currently pay dividends.
            What is Inspira Technologies Oxy BHN’s EPS estimate?
            Inspira Technologies Oxy BHN’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Inspira Technologies Oxy BHN have?
            Inspira Technologies Oxy BHN has 25,619,276 shares outstanding.
              What happened to Inspira Technologies Oxy BHN’s price movement after its last earnings report?
              Inspira Technologies Oxy BHN reported an EPS of -$0.24 in its last earnings report, missing expectations of -$0.22. Following the earnings report the stock price went down -6.299%.
                Which hedge fund is a major shareholder of Inspira Technologies Oxy BHN?
                Currently, no hedge funds are holding shares in IINN

                Company Description

                Inspira Technologies Oxy BHN

                Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. The company was incorporated in 2018 and is based in Ra'annana, Israel.

                Inspira Technologies Oxy BHN (IINN) Earnings & Revenues

                Similar Stocks
                Company
                Price & Change
                Follow
                Cytosorbents
                Biomerica
                Varex Imaging
                Co-Diagnostics
                Movano

                Ownership Overview

                18.58%0.01%0.16%99.83%
                18.58%
                Insiders
                0.16% Other Institutional Investors
                99.83% Public Companies and
                Individual Investors

                Options Prices

                Currently, No data available
                ---
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis